Detalhe da pesquisa
1.
Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and ß2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD).
Bioorg Med Chem Lett
; 41: 127975, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753262
2.
Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3Kδ inhibitors.
Eur J Med Chem
; 254: 115331, 2023 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37094451
3.
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).
Bioorg Med Chem Lett
; 22(1): 138-43, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22153340
4.
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and ß2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
J Med Chem
; 65(15): 10233-10250, 2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901125
5.
Mental and physical health in family members of substance users: A scoping review.
Drug Alcohol Depend
; 219: 108439, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333362
6.
Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases.
J Med Chem
; 61(11): 4757-4773, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741897
7.
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
J Med Chem
; 52(17): 5408-19, 2009 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19725580